Target intelligence / Profile preview

Ribosomal protein S16 pseudogene 9 (RPS16P9)

Target: RPS16P9
Molecular classification: Other (pseudogene), processed pseudogene

Overview

Ribosomal protein S16 pseudogene 9 is a processed pseudogene in the human genome related to the ribosomal protein S16 gene (RPS16). Processed pseudogenes are non-functional DNA sequences, typically arising from retrotransposition of mRNA from protein-coding parent genes, and lack the intronic structure and most regulatory sequences of their parent[5][6]. RPS16P9 is not transcribed into a functional protein and is not involved in ribosomal assembly, RNA binding, or protein synthesis. Unlike its functional counterpart (RPS16), RPS16P9 has no established role in biology or disease and is not considered a target for therapeutic intervention[3][5][6].

Other names: Ribosomal protein S16 pseudogene 9RPS16P9RP S16 P9

Beyond the preview

Go deeper on Ribosomal protein S16 pseudogene 9 (RPS16P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S16 pseudogene 9 (RPS16P9).

Explore the full profile